Viimane versioon :
28/04/2024
Uurimisrühmad - University Hospital “Virgen del Rocío, Department of Pharmacy   Pdf  
Hispaania
Haigla
University Hospital “Virgen del Rocío, Department of Pharmacy
Séville
Viited   Viited   (8)  
1
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa.
Cordero-Ramos J, Merino-Bohórquez V, Delgado-Valverde , Barros-Tornay R, Cameán-Fenández M, Calleja-Hernández M.A. ()
EJHP - 2020 -
2
Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients.
Merino-Bohorquez, Delgado-Valverde M, Garcia-Palomo M, Dàvila- Pousa MC, Canete C, Villaronga M, Rodriguez-Marrodan B, Lopez-Ro (vicente.merino.sspa@juntadeandalucia.es)
Pharm Dev Technol - 2019 -
3
Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma.
Merino-Bohorquez V, Casas M, Caracuel F, Camean M, Fernandez-Anguita M.J, Ramirez*Soto G, Lucero M.J. (vicenmb@hotmail.com)
Pharm Dev Technol - 2014 -
4
Estabilidad de la solución de gentamicina y heparina para sellado de catéter.
Villaba-Moreno AM, Gil-Navarro MV, Cotrina-Luque J, Pérez-Moreno MA, Chamorro-de Vega E. (angelavm_21@hotmail.com)
OFIL - 2014 - 24;2:86-90
5
Chemical stability of bortezomib solutions in original manufacturer vial at room temperature and in syringe at 4°C.
Berruezo garcia J, Espinosa Bosch M, Sanchez Rojas F, Bosch Ojeda C (fsanchezr@uma.es)
Int J Pharm Bio Sci - 2013 - ; 3, 1: 449-458.
6
Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
Casas M, Alvarez J, Lucero M. (mjlucero@us.es)
Pharm Dev Technol - 2013 -
7
Chemical stability of bortezomib solutions in original manufacturer vials.
Bosch-Ojeda C, Sanchez-Rojas M.F, Espinosa-Bosch M. (fsanchezr@uma.es)
Int J Pharm Bio Sci - 2012 - ; 2, 3: 344-350.
8
Stability of tirofiban hydrochloride in 0.9% sodium chloride injection for 30 days.
Garabito MJ, Jimenez L, Bautista J, Santos-Rubio MD, Perez Rodrigo I. ()
Am J Health-Syst Pharm - 2001 - ; 58: 1850-1851.

Ingredientide nimekiri   Molekulid uuritud   (9)  
Vähiravimite Süsteravim Bortezomib
Antihüpertensiivne ravim Suukaudne lahus Captopril
Antihüpertensiivne ravim Suukaudne lahus Clonidine hydrochloride
Antihüpertensiivne ravim Suukaudne lahus Enalapril maleate
Antibiootikum Süsteravim Gentamicin sulfate
Antikoagulant Süsteravim Heparin sodium
Mitmesugune Salv Resorcinol
Beetablokaator Salv Timolol maleate
Antikoagulant Süsteravim Tirofiban

  Mentions Légales